US Patent Issued to STRIKE PHARMA on May 19 for "CD40 binding protein, bispecific conjugate thereof and method of treating cancer" (Swedish Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,643, issued on May 19, was assigned to STRIKE PHARMA AB (Lund, Sweden).

"CD40 binding protein, bispecific conjugate thereof and method of treating cancer" was invented by Sara Mangsbo (Uppsala, Sweden), Helena Persson Lotsholm (Jarfalla, Sweden) and Oskar Andersson (Lidingo, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a binding protein that binds CD40 and is an agonist thereof. In a particular embodiment the invention provides an agonistic anti-CD40 antibody. Also provided are bispecific conjugates comprising the binding protein, and complexes comprising the bispecific conjugates non-covalently bound to a tag construct comprisin...